Balchem (NASDAQ:BCPC) announced its quarterly earnings data on Tuesday. The basic materials company reported $0.68 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.06, Bloomberg Earnings reports. The business had revenue of $159.26 million for the quarter. Balchem had a net margin of 11.11% and a return on equity of 14.68%.
Shares of Balchem (NASDAQ:BCPC) opened at $75.12 on Wednesday. The firm has a market cap of $2,439.04, a PE ratio of 30.12 and a beta of 1.04. The company has a quick ratio of 1.49, a current ratio of 2.16 and a debt-to-equity ratio of 0.35. Balchem has a fifty-two week low of $70.23 and a fifty-two week high of $89.50.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Santa Monica Partners LP bought a new position in Balchem in the fourth quarter worth approximately $43,548,000. Conestoga Capital Advisors LLC lifted its stake in Balchem by 49.1% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 533,894 shares of the basic materials company’s stock valued at $43,400,000 after acquiring an additional 175,850 shares during the period. Sei Investments Co. lifted its stake in Balchem by 6,294.8% during the 3rd quarter. Sei Investments Co. now owns 157,633 shares of the basic materials company’s stock valued at $1,922,000 after acquiring an additional 155,168 shares during the period. BlackRock Inc. lifted its stake in Balchem by 3.3% during the 4th quarter. BlackRock Inc. now owns 3,964,398 shares of the basic materials company’s stock valued at $319,530,000 after acquiring an additional 125,074 shares during the period. Finally, Assenagon Asset Management S.A. acquired a new stake in Balchem during the 4th quarter valued at approximately $5,698,000. Institutional investors and hedge funds own 88.14% of the company’s stock.
WARNING: This article was reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/3228690/balchem-bcpc-announces-earnings-results.html.
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.